Fundz

Merit Medical completes merger with Biolife Delaware

PUBLIC · MMSIFeb 28, 2026

Acquiring Company

Merit Medical Systems  Inc

Acquired Company

Biolife Delaware

South JordanDelawareManufacturingBiotechnologyHealth CareMedicalBiotechnologyHealth CareMedicalMedical Device

Description

Merit Medical Systems has recently completed its merger with Biolife Delaware, enhancing its capabilities in interventional medical products. This merger aligns with Merit Medical's 'Continued Growth Initiatives' Program aimed at expanding their product offerings. Additionally, Merit Medical acquired the C2 CryoBalloon device, signaling a commitment to innovating within the healthcare sector.

Who to call at Merit Medical Systems  Inc, and when

When Merit Medical Systems  Inc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Merit Medical Systems  Inc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Merit Medical Systems  Inc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Merit Medical Systems  Inc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Merit Medical Systems  Inc

Location

1600 West Merit Park Way

South Jordan, Utah, United States

About

Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit strives to be the most customer-focused company in healthcare. Merit is determined to make a difference by understanding its customers’ needs and innovating and delivering a diverse range of products that improve the lives of people and communities throughout the world. Merit believes that long-term value is created for its customers, employees, shareholders, and communities when it focuses outward and is determined to deliver an exceptional customer experience.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Merit Medical Systems  Inc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jason
Likely contact at this company
••••••••@••••••••

See Jason's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Merit Medical Systems  Inc's next move

Learn about Strategic plan

Frequently asked

Who acquired Biolife Delaware?

Biolife Delaware was acquired by Merit Medical Systems  Inc, based in South Jordan. The deal was reported on February 28, 2026. Merit Medical Systems, Inc. Merit Medical Systems  Inc is publicly traded (MMSI) and operates in Manufacturing.

When did Merit Medical Systems  Inc acquire Biolife Delaware?

Merit Medical Systems  Inc's acquisition of Biolife Delaware was reported on February 28, 2026. Merit Medical Systems has recently completed its merger with Biolife Delaware, enhancing its capabilities in interventional medical products. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Biolife Delaware do?

Biolife Delaware is a company focused on providing advanced medical solutions and technologies. It specializes in developing innovative products for interventional medical applications. The firm aims to enhance healthcare delivery through cutting-edge devices. It is privately held, operating in Biotechnology, and is based in Delaware.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.